Home | Sitemap | Search | Contact A- A A+
    Public Member Support us  

IBCSG 26-02 / BIG 4-02 (PERCHE) 

A phase III trial evaluating the role of chemotherapy as adjuvant therapy for premenopausal women with endocrine responsive breast cancer who receive endocrine therapy

Premenopausal Endocrine Responsive Chemotherapy Trial (PERCHE)


please click on the picture to see a larger version

Results & Publications



Study Chairs
BIG: Dr. Rosalba Torrisi - Milano, Italy
US Intergroup: Dr. Edith A. Perez - Jacksonville, USA

Dr. Meredith Regan

Trial Coordinators
Holly Shaw, Vanessa Palermo

Data Managers
Karolyn Scott, Jocelyn Swick, Monica Greco, Adriana Mora de Karausch, Adrianna Cesario, Amy Dickinson, Monique Fortunato, Vanessa Palermo, Patricia Gonzales

IBCSG Data Management Center/FSTRF
4033 Maple Road
Amherst, New York 14226 USA
Phone: +1 716 834 0900
Fax: +1 716 833 3990
Email: ibcsg24-26_STP@fstrf.org

Date of Activation
August 4, 2003

Date of Closure
December 31, 2006

Targeted Accrual
1750 patients

Final Accrual
29 patients

Results Publications Results & Publications
Other Pathology


New publications are available 

IBCSG open positions: Lead Clinical Research Associate / CRA 100%

The next IBCSG Annual Meeting will take place in Vienna, Austria on March 21st and 22nd, 2015 in

All News